358 Pill - white oval, 9mm
Pill with imprint 358 is White, Oval and has been identified as Metoprolol Succinate Extended-Release 200 mg. It is supplied by Ethex Corporation.
Metoprolol is used in the treatment of Heart Failure; Angina; High Blood Pressure; Angina Pectoris Prophylaxis; Heart Attack and belongs to the drug class cardioselective beta blockers. Risk cannot be ruled out during pregnancy. Metoprolol 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 358
Metoprolol Succinate Extended-Release
- Imprint
- 358
- Strength
- 200 mg
- Color
- White
- Size
- 9.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Cardioselective beta blockers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ethex Corporation
- National Drug Code (NDC)
- 58177-0358 (Discontinued)
- Inactive Ingredients
-
calcium stearate,
carboxymethylcellulose sodium,
carnauba wax,
croscarmellose sodium,
glyceryl behenate,
hypromelloses,
maltodextrin,
methacrylic acid - methyl methacrylate copolymer (1:1),
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
povidone,
sodium stearyl fumarate,
titanium dioxide,
triacetin,
triethyl citrate
Note: Inactive ingredients may vary.
Related images for "358"
More about metoprolol
- Check interactions
- Compare alternatives
- Reviews (656)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: cardioselective beta blockers
- Breastfeeding
- En español
Patient resources
- Metoprolol drug information
- Metoprolol (Intravenous) (Advanced Reading)
- Metoprolol Extended-Release Tablets
Other brands
Professional resources
- Metoprolol monograph
- Metoprolol (FDA)
- Metoprolol Succinate (FDA)
- Metoprolol Succinate ER Capsules (FDA)
- Metoprolol Succinate ER Tablets (FDA)
Other brands
Lopressor, Toprol-XL, Kapspargo Sprinkle
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.